Concepedia

Marco Brugia

MB

12

Publications

407

Citations

11

H-Index

1992

Active since

Affiliations

Azienda Ospedaliero-Universitaria Careggi(Current)

University of Florence

University of Rome Tor Vergata

Agostino Gemelli University Polyclinic

European Society for Sexual Medicine

Marco Brugia is an author at Azienda Ospedaliero-Universitaria Careggi specializing in oncology, pharmacotherapy, and medicine.

ORCID

Top concepts

Publications per year

1992–2022

12

Publications

12

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO

Daniele Rossini, Carlotta Antoniotti, Sara Lonardi et al. · Journal of Clinical Oncology · 2022 · 71 citations · Full text

Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: A single‐center experience with 31 patients

Bruno Neri, Agnese Vannini, Marco Brugia et al. · International Journal of Urology · 2012 · 49 citations · Full text

, , +12

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study

Francesca Salvianti, Stefania Gelmini, Irene Mancini et al. · British Journal of Cancer · 2021 · 42 citations · Full text

Results of the observational prospective RealFLOT study

Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino et al. · BMC Cancer · 2021 · 42 citations · Full text

Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy

Rossella Rubino, Andrea Marini, Giandomenico Roviello et al. · Endocrine · 2021 · 37 citations · Full text

Rows per page

1–5 of 12